All In MedTech

Device Trial Radar · NCT05848401

Biosound Therapy as a Treatment for Long COVID Patients

Biosound Therapy as a Treatment for Long COVID Patients: A Randomized Pilot Trial

Last checked: Nov 19, 2026Latest source record: May 8, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

13

Actual

Start

Apr 29, 2021

Primary completion

Jan 5, 2022

Study completion Jan 19, 2022

Sponsor

Lead sponsor
Anxiety Relief CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 8, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 20 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aimed to explore the impact of the Biosound Therapy Systerm on long COVID symptoms while determining feasibility of a future full-scale Randomized Controlled Trial. It was hypothesized that Biosound treatment would significantly improve long COVID. The goal of this clinical trial is to learn about Biosound Therapy System's impact on long COVID symptoms. The main questions it aims to answer are: * How does Biosound Therapy impact long COVID symptoms? * Is the protocol for this trial feasible for a future full-scale Randomized Controlled Trial? Participants with long COVID symptoms will be assigned to a control group and treatment group. The control group will receive no treatment. The treatment group will have 8 sessions of Biosound Therapy. Researchers will compare the treatment and control group to see if there's a difference in long COVID symptoms.

Conditions

  • Long COVID

Interventions

  • Biosound Therapy SystemDevice

    Biosound Therapy consists of biofeedback, vibroacoustic therapy synchronized with music that plays binaural beats, and video content.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Patient Health Questionnaire (PHQ-9)Time frame: 4 weeks
  2. Generalized Anxiety Disorder 7-item scale (GAD-7)Time frame: 4 weeks
  3. Cambridge Brain Sciences (CBS) tasksTime frame: 4 weeks

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Anxiety Relief Center

    Fishers, Indiana

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.